Royal Bank Of Canada Tekla Life Sciences Investors Transaction History
Royal Bank Of Canada
- $422 Billion
- Q1 2024
A detailed history of Royal Bank Of Canada transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Royal Bank Of Canada holds 43,302 shares of HQL stock, worth $576,782. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,302
Previous 44,532
2.76%
Holding current value
$576,782
Previous $599,000
1.5%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HQL
# of Institutions
80Shares Held
8.52MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.46MShares$32.8 Million0.58% of portfolio
-
Morgan Stanley New York, NY484KShares$6.45 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA481KShares$6.41 Million0.54% of portfolio
-
Allspring Global Investments Holdings, LLC431KShares$5.75 Million0.01% of portfolio
-
Aqr Arbitrage LLC Greenwich, CT387KShares$5.16 Million0.32% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...